Abstract
Glucocorticoid use results in an increase risk for fractures. Over the past 10 years, we have a greater understanding of the epidemiology, pathophysiology, prevention and treatment of glucocorticoid induced osteoporosis. This article reviews these recent findings and selective practice guidelines.
MeSH terms
-
Calcitonin / therapeutic use
-
Calcium / therapeutic use
-
Diphosphonates / therapeutic use
-
Fluorides / therapeutic use
-
Glucocorticoids / adverse effects*
-
Hormone Replacement Therapy
-
Humans
-
Osteoporosis / chemically induced*
-
Osteoporosis / drug therapy*
-
Osteoporosis / etiology
-
Vitamin D / therapeutic use
Substances
-
Diphosphonates
-
Glucocorticoids
-
Vitamin D
-
Calcitonin
-
Fluorides
-
Calcium